Compliance Strategy for Small to Midsized Companies

February 22, 2013

 

Published for Pharmaceutical Compliance Monitor

On Feb. 20, 2013, Jim Hoover’s article, “Compliance Strategy for Small to Midsized Companies,” published in the online version of Pharmaceutical Compliance Monitor. In the article, Jim discusses the basic steps that small to mid-sized pharmaceutical companies should take when conducting an internal investigation. He instructs  companies to carefully consider the scope and limits of the investigation, who should conduct the investigation, how to protect the relevant privileges, and the possible outcomes of the investigation, prior to conducting the investigation. By fully considering these factors, Jim suggests that companies will be in a better position to correct any problems identified and determine whether or not self-disclosure is warranted. For the full article, please click here.  





Legal Disclaimer:
No representation is made that the quality of services to be performed is greater than the quality of legal services performed by other lawyers.

Featured Attorneys

send article

TESTIMONIALS

  • "...In terms of bang for the buck they are one of our best firms."

    -Chambers 2012

  • “A very solid and very quiet lawyer, unassuming but good. He’s on my shortlist of people to send work to…"

    -Chambers 2012

  • “A very good lawyer.”

    -Chambers 2012

  • “He is very well respected in the clinical field. He pulls his sleeves and gets involved with you.”

    -Chambers 2012

  • “Semi-retired, still working but not in full force. He makes the firm.”

    -Chambers 2012